cagrisema phase 3 results 2025 semaglutide cagrilintide obesity Cagrilintide–Semaglutide in Adults with Overweight or and Type 2 Diabetes cagrilintide clinical trials results Comparative

In September 2025, the FDA sent approximately 100 cease-and-desist letters targeting deceptive direct-to-consumer advertising for compounded drugs

Dosage & Administration Take as directed by a healthcare professional Usually one capsule daily after meals Swallow whole with water Do not exceed recommended dose Side Effects Mild gastric discomfort Nausea (rare) Headache (rare) Generally well tolerated Precautions Consult doctor before use in pregnancy or lactation Use cautiously in patients with medical conditions Avoid overdose Not a substitute for a balanced diet Storage Store in a cool, dry place away from sunlight

OZEMPIC Prescribing Information

Funding This research was supported by the National Natural Science Foundation of China (No

Phase 1: weeks 1 through 4 (the adjustment period) This is the hardest phase for most people

If you take thyroid medications, iron, or antibiotics: Put several hours between when you take those and berberine